Almuqati AL,Alluqmani MS,Balhareth SH,Alosaimi MA,Alosaimi MM,Alzughaibi AM .2020 .Evaluation of Role of Family Physicians in Management and Diagnosis of Hypertension in Primary Health Care Centers: A Simple Literature Review. J Adv Pharm Educ Res, 9(1) : 105-9.
Sinuraya RK,Rianti A,Suwantika AA .2021 .Cost minimization of cardiovascular disease (CVD) drugs in primary healthcare centers in Bandung, Indonesia. J Adv Pharm Edu Res, 10(1) : 63-9.
Chrysant SG,Chrysant GS,Desai A. .2005 .Current status of angiotensin receptor blockers for the treatment of cardiovascular diseases: focus on telmisartan. J Hum Hypertens, 19(3) : 173-83.
Chobanian AV,Bakris GL,Black HR,Cushman WC,Green LA,Izzo JL .2003 .Treatment of High Blood Pressure: the JNC 7 report. The Seventh Report of the Joint National Committee on Prevention, Detection, 10(19) : 2560-72.
Marques-Vidal P,Tuomilehto J .1997 .Hypertension awareness, treatment and control in the community: is the 'rule of halves' still valid?. J Hum Hypertens, 10(4) : 213-20.
Messerli FH,Bangalore S,Bavishi C .2018 .AngiotensinConverting Enzyme Inhibitors in Hypertension. J Am Coll Cardiol, 01(13) : 1474-82.
Bakris G .2002 .Comparison of telmisartan vs. valsartan in the treatment of mild to moderate hypertension using ambulatory blood pressure monitoring. J Clin Hypertens (Greenwich), 01586(4 Suppl 1) : 6175-31.
Nishimura T,Hashimoto J,Ohkubo T,Kikuya M,Metoki H,Asayama K .2005 .Efficacy and duration of action of the four selective angiotensins II subtype 1 receptor blockers, losartan, candesartan, valsartan, and telmisartan, in patients with essential hypertension determined by home blood pressure measurements. Clin Exp Hypertens, 10(6) : 477-89.
Grassi G,Quarti-Trevano F,Mancia G .2008 .Cardioprotective effects of telmisartan in uncomplicated and complicated hypertension. J Renin Angiotensin Aldosterone Syst, 10(2) : 66-74.
Stergiou GS,Efstathiou SP,Roussias LG,Mountokalakis TD .2003 .Blood pressure- and pulse pressure-lowering effects, trough: peak ratio and smoothness index of telmisartan compared with lisinopril. J Cardiovasc Pharmacol, 10(4) : 00005344-6.
Lacourcière Y,Krzesinski JM,White WB,Davidai G,Schumacher H .2004 .Sustained antihypertensive activity of telmisartan compared with valsartan. Blood Press Monit, 10(4) : 00126097-10.
Neutel J,Smith DH .2003 .Evaluation of angiotensin II receptor blockers for 24-hour blood pressure control: meta-analysis of a clinical database. J Clin Hypertens (Greenwich), 01612(1) : 6175-63.
Smith DK,Lennon RP,Carlsgaard PB .2020 .Managing Hypertension Using Combination Therapy. Am Fam Physician, 101(6) : 341-9.
Zheng Z,Lin S,Shi H. .2010 .A systematic review and meta-analysis of telmisartan versus valsartan in the management of essential hypertension. J Clin Hypertens (Greenwich), 00287(6) : 7176-21.
Yusuf S,Teo KK,Pogue J,Dyal L,Copland I,Schumacher H .2008 .Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events. N Engl J Med, 358(15) : 1547-59.
Bryant J,Ruilope L,Segura J. .2013 .A review of the benefits of early treatment initiation with single-pill combinations of telmisartan with amlodipine or hydrochlorothiazide. Vasc Health Risk Manag, 9 : 521.
Guthrie RM .2011 .Review: a single-pill combination of telmisartan plus amlodipine for the treatment of hypertension. Postgrad Med, 11(6) : 58-65.
Sharma AM,Davidson J,Koval S,Lacourcière Y.,Telmisartan Y. .2007 ./hydrochlorothiazide versus valsartan/hydrochlorothiazide in obese hypertensive patients with type 2 diabetes: the SMOOTH study. Cardiovasc Diabetol, 10 : 1475.
Sung KC,Oh YS,Cha DH,Hong SJ,Won KH,Yoo KD . .. Efficacy and Tolerability of Telmisartan/Amlodipine + Hydrochlorothiazide Versus Telmisartan/Amlodipine Combination Therapy for Essential, 20 : .